AI in Action E518: Drew Linsley, Co-Founder and CEO at Operant Biopharma
AI in Action, Podcast | June 24 2024 | JP Valentine
Welcome to episode 518 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.
Today’s guest is Drew Linsley, Co-Founder and CEO at Operant Biopharma. Operant Biopharma’s AI-powered robotic microscope learns to design drugs by watching and controlling diseases over time. Their platform autonomously designs biological experiments, discovering and optimizing disease treatments. The company focuses on high-need areas like neurodegenerative and kidney diseases, aiming to horizontally address multiple indications and out-license discoveries, blending AI and biology for innovative therapeutic development.
Drew is also an Assistant Professor (Research) in Computational Neuroscience and AI at Brown University. He studies biological and artificial intelligence, and believes we need artificial vision to create intelligent machines capable of reasoning about the world. However, existing artificial vision systems struggle with many visual challenges that we routinely solve in our daily lives. He looks to biological vision to inspire new solutions to these challenges in artificial vision.
In this episode, Drew talks about:
Applying AI to analyze disease data and guide therapeutics autonomously
How Robotic microscopy tracks dynamic biology to aid disease treatment advancements
How AI optimizes drug discovery pipeline & manipulates cellular states for treatment
Applying AI to drive horizontal drug development for diverse indications
Their unique staffing needs within AI, biology and neuroscience
To find out more about all the great work happening within Operant Biopharma, check out the website www.operant.bio. You can also connect with Drew directly on LinkedIn or find out more about his research at sites.brown.edu/drewlinsley.
If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.
Subscribe to The Alldus Podcast:
Welcome to episode 518 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.
Today’s guest is Drew Linsley, Co-Founder and CEO at Operant Biopharma. Operant Biopharma’s AI-powered robotic microscope learns to design drugs by watching and controlling diseases over time. Their platform autonomously designs biological experiments, discovering and optimizing disease treatments. The company focuses on high-need areas like neurodegenerative and kidney diseases, aiming to horizontally address multiple indications and out-license discoveries, blending AI and biology for innovative therapeutic development.
Drew is also an Assistant Professor (Research) in Computational Neuroscience and AI at Brown University. He studies biological and artificial intelligence, and believes we need artificial vision to create intelligent machines capable of reasoning about the world. However, existing artificial vision systems struggle with many visual challenges that we routinely solve in our daily lives. He looks to biological vision to inspire new solutions to these challenges in artificial vision.
In this episode, Drew talks about:
Applying AI to analyze disease data and guide therapeutics autonomously
How Robotic microscopy tracks dynamic biology to aid disease treatment advancements
How AI optimizes drug discovery pipeline & manipulates cellular states for treatment
Applying AI to drive horizontal drug development for diverse indications
Their unique staffing needs within AI, biology and neuroscience
To find out more about all the great work happening within Operant Biopharma, check out the website www.operant.bio. You can also connect with Drew directly on LinkedIn or find out more about his research at sites.brown.edu/drewlinsley.
If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.
Subscribe to The Alldus Podcast:
share
related podcasts
AI in Action E563: Building Enterprise AI Agents at Scale with Crafting’s Sumeet Vaidya
Welcome to episode 563 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts…
Women in ServiceNow E16: People Before Platforms: The Human Side of ServiceNow Transformation with ServiceNow’s Kim Beene
Welcome to episode 16 in our Women in ServiceNow series Alldus podcast, our series dedicated to showcasing the incredible women leading the way in the ServiceNow ecosystem. Powered by Alldus International, host Ailsa Cassie brings you inspiring conversations with trailblazing women who are driving innovation, breaking barriers, and shaping the future of ServiceNow and the…
Women in ServiceNow E15: Bridging People, Process & Technology with Aramco Europe’s Barbara Middelkoop Meijsen
Welcome to the episode 15 in our Women in ServiceNow series Alldus podcast, our series dedicated to showcasing the incredible women leading the way in the ServiceNow ecosystem. Powered by Alldus International, host Ailsa Cassie brings you inspiring conversations with trailblazing women who are driving innovation, breaking barriers, and shaping the future of ServiceNow and…